Bio-Conscious Announces Breakthrough in Forecasting High-Risk Diabetic Events Using Machine Learning (ML) Techniques and CGM data

Bio Conscious Technologies Inc. ("Bio Conscious Technologies" or the "Company"), a leading Artificial Intelligence (AI) innovator in healthcare/diabetes technology, has announced a breakthrough in forecasting high-risk diabetic events using CGM data and advanced machine learning (ML) techniques. The Company has published proprietary AI models on Amazon AWS, enabling Endocrinologists, third-party users, scientific organizations, and app developers to help patients with diabetes improve glucose control dynamics.

This breakthrough has been achieved through Bio Conscious Technologies' innovative use of ML algorithms, which accurately anticipate high-risk diabetic events based on CGM data. We believe this breakthrough represents a significant advancement in the field of Diabetes technology and has the potential to revolutionize the way medical professionals monitor and treat patients with Diabetes.

"This breakthrough is consistent with our vision to do more with CGM data. Specifically, we can use CGM data to forecast adverse glucose excursions with a much longer horizon (hours vs. minutes) and higher accuracy when compared to metabolic models that are currently available. This is just the beginning," said Amir Hayeri, CEO of Bio Conscious Technologies. "Bio Conscious Technologies is proud to announce this groundbreaking achievement. Our AI breakthrough can potentially transform every aspect of the battle against diabetes through early detection and classification of Dysglycemia using CGMs.

Classification of Dysglycemia can revolutionize diabetes care, improve personalized medicine and help detect other glucose-based conditions such as cognitive decline and Alzhemier's disease. Our current algorithm could optimize healthcare operations and transform population health monitoring, ultimately enhancing our understanding of the nuanced relationship between glucose dynamics and other chronic conditions. AI will be our gateway to a world where chronic diseases are not just managed but potentially eradicated.``

Bio Conscious' new technology is particularly useful for people with high glucose variability and severe glucose excursions, who are at high risk for a variety of medical events, including hypoglycemia and hyperglycemia. By anticipating these events before they occur, medical professionals can take preemptive measures to prevent them, potentially saving lives and reducing healthcare costs.

Bio Conscious Technologies will publish more details about these models soon and welcomes hearing from parties interested in our technology. By making these models available on Amazon AWS, to third-party users, scientific organizations, and app developers, Bio Conscious is creating a new era of healthcare collaboration and innovation.

View Article Published at Access News Wire